R. Ball

发表

Synthesis and structure of five-coordinate bis(hydrocarbyl)iridium(III) complexes of the formula Ir(R)R′[N(SiMe2CH2PPh2)2]

M. D. Fryzuk, P. MacNeil, R. Massey, 1989 .

Carbonyl-η-hexamethylbenzene complexes of osmium. Carbon-hydrogen activation by (η-C6Me6)Os(CO)(H)2

W. Kiel, R. Ball, W. Graham, 1990 .

Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

W. M. Sanders, T. Tucker, M. Goldman, 1994, Journal of Medicinal Chemistry.

Diffusion of Xe in UO2

Robin W. Grimes, R. Grimes, R. Ball, 1990 .

Systematic approach to conformational sampling for assigning absolute configuration using vibrational circular dichroism.

James F Cuff, X. Gong, C. Welch, 2014, Journal of medicinal chemistry.

Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.

R. Young, J. Mancini, M. Turner, 2003, Journal of medicinal chemistry.

Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.

H. Broughton, V. Matassa, R. Ball, 1996, Journal of medicinal chemistry.

Calculation of structural and defect properties of α-U3O8

P. Dickens, R. Ball, 1991 .

Chemistry of platensimycin

R. Ball, Sheo B. Singh, N. Tsou, 2007 .

Synthesis of antifungal glucan synthase inhibitors from enfumafungin.

Shane W. Krska, R. Ball, M. McLaughlin, 2012, The Journal of organic chemistry.

Synthesis and muscarinic receptor pharmacology of a series of 4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridine bioisosteres of arecoline.

K. Bogeso, P. Krogsgaard‐Larsen, H. Bräuner‐Osborne, 1999, Bioorganic & medicinal chemistry.

Crystal state and solution conformation of the B blood group trisaccharide alpha-L-Fucp-(1-->2)-[alpha-D-Galp]-(1-->3)]-beta-D-Galp-OCH3.

A. Otter, D. Bundle, R. Ball, 1999, European journal of biochemistry.

Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.

L. Shearman, Richard Z. Chen, R. Ball, 2010, Journal of medicinal chemistry.

Asymmetric Synthesis of a Glucagon Receptor Antagonist via Friedel–Crafts Alkylation of Indole with Chiral α-Phenyl Benzyl Cation

Jeremy P. Scott, L. Tan, R. Ball, 2012 .

Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.

D. Macintyre, Howard Y. Chen, R. Nargund, 2010, Bioorganic & medicinal chemistry letters.

Diastereoselective Friedel-Crafts alkylation of indoles with chiral alpha-phenyl benzylic cations. Asymmetric synthesis of anti-1,1,2-triarylalkanes.

R. Ball, John Y. L. Chung, N. Tsou, 2008, Organic letters.

Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties

Steven V. Fox, John D. Schreier, S. Doran, 2012, ChemMedChem.

Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor Agonists.

Yun-ping Zhou, E. Sherer, A. Howard, 2014, ACS medicinal chemistry letters.

Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate

R. Ball, N. C. Payne, 1977 .

2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathways.

L. Gantert, R. DeVita, R. Hargreaves, 2013, Journal of medicinal chemistry.

Potent benzoazepinone γ-secretase modulators with improved bioavailability.

C. Kenific, A. Szewczak, C. Moxham, 2015, Bioorganic & medicinal chemistry letters.

Development of L-689,065 - the prototype of a new class of potent 5-lipoxygenase inhibitors

D. Riendeau, P. Prasit, S. Charleson, 1992 .

Careful Navigation of the Crystallographic Landscape of MK-8970: A Racemic Acetal Carbonate Prodrug of Raltegravir

Jimmy O. DaSilva, R. Ball, R. Reamer, 2015 .

Complexes of meso bidentate ligands. The crystal structure of the racemic modification of cis-C2-anti-[oxalatobis(2R,4S-diaminopentane)cobalt(III)] perchlorate

R. Ball, R. Thurier, N. C. Payne, 1978 .

Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.

D. Macintyre, Howard Y. Chen, R. Nargund, 2010, Bioorganic & medicinal chemistry letters.

Synthesis, X-ray crystal structure and photochemistry of (η5-pentamethylcyclopentadienyl)(dicarbonyl)(dihydrido) rhenium in cyclohexane and liquid xenon solutions and in low temperature media at about 12 K

S. Kazarian, M. Poliakoff, R. Ball, 1997 .

Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation.

Scott K. Smith, T. Roemer, P. Liberator, 2008, Journal of the American Chemical Society.

A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).

M. Fisher, M. Wyvratt, R. Ball, 1994, Journal of medicinal chemistry.

1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido) bicyclo(2.2.1)heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl) piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor.

B. E. Evans, M. Bock, R. Freidinger, 1994 .

1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.

B. E. Evans, M. Bock, P. Anderson, 1994, Journal of medicinal chemistry.

Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists.

Yun-ping Zhou, E. Sherer, A. Howard, 2015, Bioorganic & medicinal chemistry letters.

The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine.

R. DeVita, H. Burns, R. Hargreaves, 2007, Bioorganic & medicinal chemistry letters.

Crystallization-induced diastereoselection: asymmetric synthesis of substance P inhibitors.

K. Rossen, R. Ball, R. Volante, 2002, Chemistry.

Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.

M. Maccoss, S. Grant, R. Chabin, 2005, Bioorganic & medicinal chemistry letters.

Conformational analysis and receptor docking of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (taranabant, MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist.

W. Hagmann, R. Ball, G. Doss, 2008, Journal of medicinal chemistry.

A straightforward approach to the synthesis of the tricyclic core of taxol

M. Bernstein, H. Perrier, S. Warder, 1993 .

X-ray structural characterization and catalytic properties of hydridobis[4,5-bis((diphenylphosphino)methyl)-2,2-dimethyl-1,3-dioxolane]rhodium(I)

D. Mahajan, R. Ball, B. James, 1981 .

Preussomerins and Deoxypreussomerins: Novel Inhibitors of Ras Farnesyl-Protein Transferase

K. Silverman, G. Bills, R. Ball, 1994 .

A Novel 3‐Substituted Benzazepinone Growth Hormone Secretagogue (L‐692, 429) (IX).

M. Fisher, M. Wyvratt, R. Ball, 1994 .

STUDIES OF RUTHENIUM(II) PORPHYRINS CONTAINING TERTIARY DIPHOSPHINE LIGANDS, INCLUDING THE CRYSTAL STRUCTURE OF (5,10,15,20-TETRAPHENYLPORPHINATO)BIS(BIS(DIPHENYLPHOSPHINO)METHANE)RUTHENIUM(II)DICHLOROMETHANE

G. Domazetis, R. Ball, B. James, 1981 .

The crystal structure of p-diethylaminobenzenediazonium hexafluorophosphate

R. Ball, R. Elofson, 1985 .

Synthesis and coordination chemistry (with platinum(II) and molybdenum(0)) of new bis(bis(trifluoromethyl)phosphano)alkanes. Structure of a new bis(phosphano)methanide complex

R. Ball, R. Cavell, I. G. Phillips, 1988 .

Potent nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae

O. Hensens, G. Tamayo-Castillo, R. Ball, 1998 .

Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.

P. D. Cook, J. Tomassini, M. Maccoss, 2004, Journal of medicinal chemistry.

Computer simulation studies of ternary uranate phases with alkali and alkaline-earth metals. Part 1.—MUO3

R. Ball, 1992 .

Amperomitric Titration of Mercury(II) with Tetraphenylarsonium Chloride

R. Ball, D. L. Manning, O. Menis, 1957 .

Structure of stereochemistry of thysanone: a novel human rhinovirus 3C-protease inhibitor from Thysanophora penicilloides

Jack L. Smith, R. Ball, Sheo B. Singh, 1991 .

Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid.

Alex M. Chen, R. Ball, D. Mathre, 2007, Chemical communications.

Powder neutron diffraction study of the mixed uranium–vanadium oxides Cs2(UO2)2(V2O8) and UVO5

S. Hull, Ş. Patat, P. Dickens, 1992 .

Fragment-Based Lead Discovery of a Novel Class of Small Molecule Inhibitors of Neuropeptide B/W Receptor Subtype 1 (GPR7).

Zhiqian Guo, N. Hastings, F. Ujjainwalla, 2020, Bioorganic & medicinal chemistry letters.

Activation of dihydrogen by ruthenium(II)-chelating phosphine complexes, and activation of dioxygen by ruthenium(II) porphyrin complexes: an update

J. Ibers, R. Ball, S. Rettig, 1987 .

Highly potent, orally active diester macrocyclic human renin inhibitors.

R A Stearns, T. Halgren, A. Weber, 1992, Journal of medicinal chemistry.

Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.

M. Struthers, R. Berger, C. Moyes, 2016, Journal of medicinal chemistry.

Asymmetric Synthesis of α,α-Difluoro-β-amino Acid Derivatives from Enantiomerically Pure N-tert-Butylsulfinimines

R. Ball, C. Homnick, N. Tsou, 2002 .

Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirements

C. Strader, C. Swain, R. Ball, 1993 .

Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

Olga Genilloud, Jun Wang, Francisca Vicente, 2006, Journal of the American Chemical Society.

Efficient synthesis of the optically active dihydropyrimidinone of a potent α1A- selective adrenoceptor antagonist

M. Chartrain, E. Hu, D. Sidler, 2002 .

Conformational analysis of δ-lactams

C. Bayly, M. Bernstein, Y. Leblanc, 1994 .

Synthesis, molecular modeling, 2-D NMR, and biological evaluation of ILV mimics as potential modulators of protein kinase C

Yuan-Ping Pang, Slobodan I Macura, John S. Lazo, 1993 .

Zinc(2+)-catalyzed decomposition of a tris(imidazol-2-yl)phosphine. Crystal and molecular structure of [bis(4,5-diisopropylimidazol-2-yl)phosphinic acid]dichlorozinc hydrate

R. S. Brown, R. Ball, J. Cocho, 1984 .

Polyazamacrocycles. V. Structure of Isomeric 3,5,7,7,10,12,14,14-Octamethyl-1,4,8,11-tetraazacyclotetradecanes

Ashutosh Kumar Singh, J. Lown,, R. Ball, 1989, Bulletin of the Chemical Society of Japan.

Synthesis and structure of [(η-C5Me5)Ir(CO)]2

R. Ball, W. Graham, J. Hoyano, 1990 .

Stereoselective synthesis of the hydroxyethylene isostere of the HIV protease (Tyr-Pro) cleavage site

P. Darke, J. Thies, W. J. Thompson, 1992 .

Asymmetric synthesis of the northern segment of ephedradine C

R. Ball, N. Tsou, J. Castro, 2000 .

4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor.

P D Leeson, P. Leeson, C. Ragan, 1997, Journal of medicinal chemistry.

An efficient preparation of vinamidinium hexafluorophosphate salts.

I. Davies, R. Ball, M. Palucki, 2000, The Journal of organic chemistry.

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.

T. Bach, A. Alberts, J. C. Chabala, 1992, Journal of medicinal chemistry.

Synthesis and Structure of ((η-C5Me5)Ir(CO))2.

R. Ball, W. Graham, J. Hoyano, 1990 .

Inhibition of human leukocyte elastase. 4. Selection of a substituted cephalosporin (L-658,758) as a topical aerosol.

R. Ball, S. K. Shah, P. Davies, 1992, Journal of medicinal chemistry.

Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitors.

I. Kariv, C. Moxham, Thomas A. Miller, 2012, Bioorganic & medicinal chemistry letters.

Asymmetric synthesis of conformationally constrained cis-1-amino-1-phenylcyclohexan-2-ol

C. Senanayake, R. Ball, P. Reider, 1996 .

ZINC(2+)-CATALYZED DECOMPOSITION OF A TRIS(IMIDAZOL-2-YL)PHOSPHINE. CRYSTAL AND MOLECULAR STRUCTURE OF (BIS(4,5-DIISOPROPYLIMIDAZOL-2-YL)PHOSPHINIC ACID)DICHLOROZINC HYDRATE

R. S. Brown, R. Ball, J. Cocho, 1984 .

Chemoselectivity in the Pd‐Catalyzed Cyclization of 1,6‐Enynes and Proof of the Relative Configuration of the New Stereogenic Centers

B. Trost, A. Hashmi, R. Ball, 2001 .

Complexes of substituted benzothiazoles. 2. Copper(II) complexes of the 'tripod' ligand tris(2-benzothiazolylmethyl)amine

L. Thompson, R. Ball, J. Trotter, 1980 .

A novel synthetic approach toward the zaragozic acids core structure

R. Ball, H. Koyama, G. D. Berger, 1994 .

Activation of dihydrogen by ruthenium(II)-chelating phosphine complexes, and activation of dioxygen by ruthenium(II) porphyrin complexes: an update

J. Ibers, R. Ball, S. Rettig, 1987 .

Stereoselective addition of 2-phenyloxazol-4-yl trifluoromethanesulfonate to N-sulfinyl imines: application to the synthesis of the HCV protease inhibitor boceprevir.

R. Ball, Cameron J. Cowden, W. Morris, 2013, The Journal of organic chemistry.

SYNTHESIS OF THE TETRACYCLIC CARBON CORE OF MENOGARIL UTILIZING THE BENZANNULATION REACTION OF A FISCHER CARBENE COMPLEX AND AN ALKYNE

R. Ball, Jing Su, W. Wulff, 1998 .

Stereoselection in the chromium mediated intramolecular [2 + 2] cycloadditions of vinyl ketenes and alkenes

R. Ball, W. Wulff, O. Kim, 1993 .

Total Synthesis and Determination of the Absolute Configuration of Epibatidine

R. Ball, H. Verrier, S. Fletcher, 1994 .

Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonists.

L. Bristow, R. Ball, S. Grimwood, 1995, Journal of medicinal chemistry.

A new series of selective COX-2 inhibitors : 5,6-diarylthiazolo[3,2-b][1,2,4]triazoles

P. Prasit, C. Brideau, C. Chan, 1997 .

Three-Component Intramolecular Two-Alkyne Annulations of Fischer Carbene Complexes: New Strategies for Steroid Synthesis

Steve Wenglowsky, R. Ball, Jianming Bao, 1994 .

THERMAL REARRANGEMENT OF THE IMMUNOSUPPRESSANT FK-506

M. Fisher, M. Wyvratt, B. Arison, 1990 .

Novel ring-chain tautomers derived from (o-formylphenyl)ethylamines

R. Ball, James D. Carroll, P. Jones, 1991 .

A concise and enantioselective synthesis of novel HIV-1 protease transition state mimics

R. Ball, B. Dorsey, Kevin Plzak, 1993 .

Metal-Catalyzed Cyclopropene Rearrangements for Benzannulation: Evaluation of an Anthraquinone Synthesis Pathway and Reevaluation of the Parallel Approach via Carbene-Chromium Complexes

M. Steigerwald, A. Gilbert, R. Ball, 1994 .

An unusual fragmentation process discovered during the course of cleavage of a camphanic acid amide

A. Kozikowski, R. Ball, Chinpiao Chen, 1990 .

Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.

R. Ball, K. Hoogsteen, A. Macleod, 1995, Journal of medicinal chemistry.

A convergent synthesis of novel conformationally restricted HIV-1 protease inhibitors

J. Vacca, R. Ball, B. Kim, 1994 .

Conformational Analysis of δ-Lactams (I).

C. Bayly, M. Bernstein, Y. Leblanc, 2010 .

Diastereoselective triple radical cyclization of a bromomethyldimethylsilyl allyl ether

R. Ball, N. Tsou, A. Kende, 1996 .

Control of stereochemistry in five-coordinate d6 complexes by ligand substitution

M. D. Fryzuk, P. MacNeil, R. Ball, 1986 .

Mitsunobu-like Processes with a Novel Triphenylphosphine-Cyclic Sulfamide Betaine

V. Matassa, R. Ball, J. L. Castro, 1994 .

The crystal and molecular structure of cis-dichloro(2,2′-o-phenylenebisbenzothiazole)copper(II)

R. Ball, J. Trotter, 1979 .

Reactions of perfluoromethyl-substituted cyclopolyphosphines with zerovalent group 10 metal complexes. Crystal and molecular structure of a [palladium] complex with a coordinated diphosphene, [Pd(.eta.2-CF3P:PCF3)(PPh3)2]

R. Ball, R. Cavell, I. G. Phillips, 1992 .

Molecular structure and absolute configuration of cis-dichloro((S)-methyl p-tolyl sulfoxide)(3-methyl-1-butene)platinum(II)

R. Ball, N. C. Payne, 1977 .

The molecular structure and absolute configuration of cis-dichloro[(S)-methyl p-tolyl sulfoxide][(R)-styrene]platinum(II)

R. Ball, N. C. Payne, 1976 .

Cycloheptatrienyl-bridged heterobimetallic complexes: facile phosphine substitution reactions of [cyclic] (.mu.-C7H7)Fe(CO)3Rh(CO)2

R. Ball, F. Edelmann, J. Takats, 1986 .

Reactivity of diosmacycles: complementary syntheses and structure Of [(µ-η1,η2-CHCH2)OS2(CO)8][BF4]

W. Kiel, R. Ball, J. Takats, 1995 .

Reactions of Perfluoromethyl‐Substituted Cyclopolyphosphines with Zerovalent Group 10 Metal Complexes. Crystal and Molecular Structure of a Complex with a Coordinated Diphosphene, (Pd(η2‐CF3P=PCF3)( PPh3)2).

R. Ball, R. Cavell, I. G. Phillips, 2010 .

Two Novel Pharmaceutical Cocrystals of a Development Compound – Screening, Scale-up, and Characterization

A. Bak, R. Ball, N. Canfield, 2012 .

Actinide poly(pyrazol-1-yl)borate complexes: synthesis and structure of hydrotris(3,5-dimethylpyrazol-1-yl)boratotrichlorotetrahydrofuran actinide(IV), M[HB(3,5-Me2Pz)3] Cl3(THF) (M=Th and U)

K. W. Bagnall, J. Matisons, J. Marçalo, 1987 .

The chemical constitution of the fuel-clad gap in oxide fuel pins for nuclear reactors

P. E. Potter, R. Ball, J. Henshaw, 1989 .

Synthesis and structure of a diphosphetene, (CF3)P(CF3)PC(SiMe3):C(SiMe3), and the coordination and metallacycle formation of several diphosphetenes with iridium(I)

R. Ball, R. Cavell, I. G. Phillips, 1988 .

Preparation and characterization of triphospholene complexes of zerovalent platinum: crystal and molecular structure of [Pt{(CF3)P(CF3)P(CF3)PC(CF3):C(CF3)}(PPh3)2]

R. Ball, R. Cavell, I. G. Phillips, 1987 .

Dicarbonyltris(.eta.2-trans-cyclooctene)ruthenium. Synthesis and molecular structure of the first stable M(CO)2(olefin)3 type compound

R. Ball, J. Takats, Friedrich-Wilhelm Grevels, 1987 .

The calculation of phase equilibria of oxide core-concrete systems

T. I. Barry, R. Ball, J. Gisby, 1993 .

Thermochemistry of selected fission product compounds

R. Konings, E. Cordfunke, R. Ball, 1993 .

The synthesis and conformational analysis of amino acid-tetrahydroanthranilic acid hybrids

R. Mosley, R. Ball, J. Tata, 2008 .

Determinaton of Molybdenum in Nitrilotriacetic Acid Medium by Derivative Polarography. Application to Solutions of Mixed Thorium-Uranium Oxides

R. Ball, D. L. Manning, O. Menis, 1960 .

Determination of Chloride by Cathodic Stripping Polarography. Application to Solutions of Uranyl Sulfate

R. Ball, D. L. Manning, O. Menis, 1960 .

SPECTROPHOTOMETRIC DETERMINATION OF YTTRIUM WITH PYROCATECHOL VIOLET

J. White, R. Ball, J. P. Young, 1960 .

Automatic Spectrophotometric Titration of Fluoride, Sulfate, Uranium, and Thorium

R. Ball, D. L. Manning, O. Menis, 1958 .

The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.

Margaret S. Wu, Rebecca T. Ruck, M. Reibarkh, 2012, ACS medicinal chemistry letters.

A Carotane Sesquiterpene as a Potent Modulator of the Maxi-K Channel from Arthrinium phaesospermum

G. Kaczorowski, G. Bills, R. Ball, 1995 .

Chemistry and Biology of Cylindrols: Novel Inhibitors of Ras Farnesyl-Protein Transferase from Cylindrocarpon lucidum.

J. Gibbs, K. Silverman, G. Bills, 1996, The Journal of organic chemistry.

Nodulisporic Acid A, a Novel and Potent Insecticide from a Nodulisporium Sp. Isolation, Structure Determination, and Chemical Transformations

O. Hensens, G. Helms, R. Ball, 1997 .

Computer-simulation study of alkali-metal insertion into α-U3O8

P. Dickens, R. Ball, 1991 .

A spectroscopic and crystallographic study of polymorphism in an aza-steroid.

R. Ball, R. Varsolona, R. Wenslow, 2000, Journal of pharmaceutical sciences.

Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding.

G. McGaughey, J. Renger, P. Coleman, 2009, Bioorganic & medicinal chemistry letters.

Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements

C. Swain, R. Ball, B. Williams, 1994 .

Fusidienol A: A Novel Ras Farnesyl-Protein Transferase Inhibitor from Phoma sp.

K. Silverman, F. Peláez, R. Monaghan, 1997, Journal of Organic Chemistry.

A Cavaet on the Swern Oxidation

R. Ball, Amos B. Smith, T. L. Leenay, 1988 .

The question of reversible formation of bromonium ions during the course of electrophilic bromination of olefins. 2. The crystal and molecular structure of the bromonium ion of adamantylideneadamantane

R. S. Brown, R. Ball, H. Ślebocka-tilk, 1984 .

Molecular structure and absolute configuration of (-)280-cis-dichloro(1-methylamino-2(s)-aminopropane)platinum(II)

R. Ball, N. J. Bowman, N. C. Payne, 1976 .

NOVEL TRANSANNULAR REARRANGEMENTS OF AZALIDE IMINOETHERS

R. Mosley, R. Ball, G. Doss, 1997 .

Fusidienol A: A Novel Ras Farnesyl‐Protein Transferase Inhibitor from Phoma sp.

K. Silverman, F. Peláez, R. Monaghan, 1998 .

Pseudo-allylic A1,3 strain as a conformational control element: Stereoselective syntheses of ψ[CH2O] pseudodipeptides

R. Ball, R. Gomez, N. Anthony, 1995 .

Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist".

A. Kozikowski, J. S. Bergmann, K. Johnson, 1993, Journal of medicinal chemistry.

SAR of cocaine: further exploration of structural variations at the C-2 center provides compounds of subnanomolar binding potency

Kenneth M. Johnson, A. Kozikowski, J. S. Bergmann, 1993 .

The discovery of potent antagonists of NPBWR1 (GPR7).

Zhiqian Guo, N. Hastings, F. Ujjainwalla, 2012, Bioorganic & medicinal chemistry letters.

ASYMMETRIC SYNTHESIS OF CDP840 BY JACOBSEN EPOXIDATION. AN UNUSUAL SYN SELECTIVE REDUCTION OF AN EPOXIDE

R. Ball, R. Volante, Woo-Baeg Choi, 1997 .

Absolute Stereochemistry of the Squalene Synthase Inhibitor Zaragozic Acid C

R. Ball, C. Santini, G. D. Berger, 1994 .

5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptor.

H. Broughton, V. Matassa, R. Ball, 1997, Journal of medicinal chemistry.

Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling

J. Phillips, F. Vicente, R. Donald, 2010, The Journal of Antibiotics.

Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality.

V. Hornak, W. Schafer, C. Welch, 2011, ACS medicinal chemistry letters.

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists.

M. Struthers, S. Galloway, S. Feighner, 2011, Bioorganic & medicinal chemistry letters.

SPORANDOL: A NOVEL ANTIPARASITIC BINAPHTHALENE FROM CHRYSOSPORIUM MERIDARIUM

O. Hensens, J. Williamson, R. Ball, 1997 .

The ground-state energies of three-body Coulomb systems calculated by the short-time Green function Monte Carlo method

B. H. Wells, R. Ball, 1990 .

The ground-state energy of the e-2e+ system calculated by the Green function Monte Carlo method

B. H. Wells, R. Ball, 1988 .

Defect calculations in solids beyond the dilute limit

Robert Allan Jackson, R. Ball, James E. Huntingdon, 1991 .

Computer simulation studies of alkali and alkaline-earth metal intercalation into uranium oxides

R. Ball, 1993 .

A comparison of the behaviour of fission gases in UO2±x and α-U3O8−z

Robin W. Grimes, R. Grimes, R. Ball, 1992 .

Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency.

Y. Pang, A. Kozikowski, I. Reynolds, 1992, Journal of Medicinal Chemistry.

Crystal state and solution conformation of the B blood group trisaccharide α-l-Fuc p -(1→2)-[α-d-Gal p ]-(1→3)]-β-d-Gal p -OCH 3

A. Otter, D. Bundle, R. Ball, 1999 .

1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.

Donald F Thompson, L. Shearman, A. Frassetto, 2009, Journal of medicinal chemistry.

3-Heteroaryl-2-pyridones: Benzodiazepine Site Ligands with Functional Selectivity for α2/α3-Subtypes of Human GABAA Receptor-Ion Channels

G. Dawson, R. Mckernan, A. Pike, 2002 .

Carbonyl-η-hexamethylbenzene Complexes of Osmium. Carbon-Hydrogen Activation by (η-C6Me6)Os(CO)(H)2.

W. Kiel, R. Ball, W. Graham, 1990 .

Molecular structure of 3,4,5-trihydro-2-oxo-1,5-ethanobenzazepine and its reaction with .beta.-amino alcohols as a model for the acylation step of the serine proteases

K. Skorey, R. S. Brown, R. Ball, 1986 .

Synthesis of C2-symmetric trans-2,6-diarylpiperidinones via aryl cuprate addition: an unexpected stereochemical outcome

R. Ball, Christopher L. Hamblett, M. Stanton, 2007 .

Crystal and molecular structure of (5,10,15,20-tetraphenylporphinato)indium(III) chloride

A. Marshall, R. Ball, J. Trotter, 1980 .

Organometallic nitrosyl chemistry. 14. Novel reactivity of LiEt3BH with [(.eta.5-C5H5)Cr(NO)2]2: conversion of a bridging nitrosyl ligand to a bridging EtNBEt2 group

R. Ball, P. Legzdins, J. Trotter, 1980 .

ORGANOMETALLIC NITROSYL CHEMISTRY. 14. NOVEL REACTIVITY OF LIET3BH WITH ((η5-C5H5)CR(NO)2)2: CONVERSION OF A BRIDGING NITROSYL LIGAND TO A BRIDGING ETNBET2 GROUP

R. Ball, P. Legzdins, J. Trotter, 1981 .

Water Activity-Mediated Control of Crystalline Phases of an Active Pharmaceutical Ingredient

R. Ball, Claire Lee, N. Tsou, 2007 .

Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation.

D. Veber, R. Freidinger, R. Ball, 1994, Bioorganic & medicinal chemistry.

Potent and Selective Oxytocin Antagonists Obtained by Chemical Modification of a Streptomyces Silvensis Derived Cyclic Hexapeptide and by Total Synthesis

D. Veber, M. Bock, R. M. Dipardo, 1990 .

Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide.

D. Veber, M. Bock, R. M. Dipardo, 1990, Journal of medicinal chemistry.

Orally active, non-peptide oxytocin antagonists

B. E. Evans, D. Veber, M. Bock, 1994 .

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

P. Anderson, W. Schleif, E. Emini, 1995, Antimicrobial agents and chemotherapy.

Synthesis of a Series of 4-(Arylethynyl)-6-chloro-4-cyclopropyl-3,4- dihydroquinazolin-2(1H)-ones as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

W. M. Sanders, P. Anderson, W. Schleif, 1994 .

Thermodynamic modelling using MTDATA: a description showing applications involving oxides, alloys and aqueous solutions.

R. H. Davies, A. Dinsdale, R. Ball, 1994 .

Delineating the pharmacophoric elements of huperzine A: importance of the unsaturated three-carbon bridge to its AChE inhibitory activity.

J H Miller, Y. Pang, A. Kozikowski, 1991, Journal of medicinal chemistry.

A New Series of Selective COX-2 Inhibitors: 5,6-Diarylthiazolo(3,2-b)( 1,2,4)triazoles.

P. Prasit, C. Brideau, C. Chan, 1997 .

Transannular cyclizations of 1,2-dithia-5,8-diazacyclodeca-4,8-dienes during borohydride reduction

J. Lown,, R. Ball, S. Sondhi, 1987 .

Transannular Cyclizations of 1,2-Dithia-5,8-diazacyclodeca-4,8-dienes During Borohydride Reduction.

J. Lown,, R. Ball, S. Sondhi, 1987 .

Site preference and binding of iodine and caesium in uranium dioxide

C. Catlow, R. Grimes, R. Ball, 1992 .

Aryl sulfones : A new class of γ-secretase inhibitors

Timothy Harrison, Euan R. Kay, U. Gerhard, 2005 .

A cascade approach to cyclic aminonitrones: reaction discovery, mechanism, and scope.

James F Cuff, R. Ball, Cheng-yi Chen, 2009, Organic letters.

Aryl sulfones: a new class of gamma-secretase inhibitors.

U. Gerhard, E. Kay, R. Ball, 2005, Bioorganic & medicinal chemistry letters.

8-Azabicyclo[3.2.1]oct-3-en-2-ones via asymmetric 1,3-dipolar cycloaddition of a homochiral 3-oxidopyridinium betaine

R. Ball, J. Kulagowski, N. Curtis, 2006 .

Zaragozic acid A, a potent inhibitor of squalene synthase: initial chemistry and absolute stereochemistry

K. Wilson, R. Ball, K. Hoogsteen, 1992 .